ST. PAUL, Minn., Nov. 14 /PRNewswire-FirstCall/ -- Hypertension Diagnostics, Inc. (OTC:HDII) (BULLETIN BOARD: HDII) , today announced financial results for the first quarter of fiscal year 2008 ended September 30, 2007. Revenue for the quarter totaled $146,352 compared to $422,485 in the prior year's first quarter ended September 30, 2006, a 65.4% decrease. The Company incurred a net loss of $456,208 for the current quarter or $(.01) per share compared with a net loss of $188,081 for the prior year's quarter or $(.00) per share. Included in the net loss of $456,208 for the quarter are total non-cash charges (expenses associated mainly with stock compensation, depreciation, stock options) of $316,976. Included in the net loss of $188,081 for the prior year's first quarter were non-cash charges of $87,206. The Company reported a cash balance of $1,467,575 on September 30, 2007, an increase from $1,376,632 reported on June 30, 2007. Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company's 2007 Annual Report on Form 10-KSB, and subsequent Quarterly Reports on Form 10-QSB, all of which were filed with the U.S. Securities and Exchange Commission, as well as others not now anticipated. Hypertension Diagnostics, Inc. Summary Financial Data Statements of Operations (Unaudited) Three Months Ended September 30, 2007 2006 Revenue: Equipment sales $91,930 $333,301 Equipment rental 46,227 75,178 Service/contract income 8,195 14,006 146,352 422,485 Cost of Sales 2,328 20,245 Gross Profit 144,024 402,240 Selling, general and administrative expenses 614,985 612,006 Operating Loss (470,961) (209,766) Other Income: Interest income 14,753 13,586 Gain on sale of property and equipment - 8,099 Total Other Income 14,753 21,685 Net Loss $(456,208) $(188,081) Basic and Diluted Net Loss per Share $(.01) $(.00) Weighted Average Shares Outstanding 39,649,316 40,157,106 Balance Sheet Data September 30, 2007 June 30, 2007 (Unaudited) (Audited) Cash and cash equivalents $1,467,575 $1,376,632 Total current assets 1,811,006 1,976,825 Total assets 1,846,288 2,020,385 Total current liabilities 842,078 582,124 Accumulated deficit (26,938,538) (26,482,330) Total shareholders' equity 994,335 1,426,143 CVProfilor is a registered trademark of Hypertension Diagnostics, Inc. Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved. Website: http://www.hdii.com/ DATASOURCE: Hypertension Diagnostics, Inc. CONTACT: Mark N. Schwartz, CEO of Hypertension Diagnostics, Inc., +1-651-687-9999 Web site: http://www.hdii.com/

Copyright